Enterococcus faecium WEFA23
The invention discloses enterococcus faecium with the function of lowering cholesterol in vitro. Enterococcus faecium WEFA23 is collected in the China General Microbiological Culture Collection Center and in the China Center for Type Culture Collection (CCTCC) in Wuhan city, with collection number o...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses enterococcus faecium with the function of lowering cholesterol in vitro. Enterococcus faecium WEFA23 is collected in the China General Microbiological Culture Collection Center and in the China Center for Type Culture Collection (CCTCC) in Wuhan city, with collection number of CCTCCM 2015785 and collection date of December 28, 2015. Enterococcus faecium is separated from excrement of infants, belongs to Gram-positive bacteria, is extremely resistant to bile salt, can maintain higher survival rate in gastrointestinal fluid, can highly yield bile salt hydrolase and has an extremely strong effect of lowering cholesterol in vitro. Enterococcus faecium WEFA23 can be used for developing functional food capable of lowering blood fat and preparing intestinal microecological preparations or can be combined with drugs to treat or prevent gastrointestinal diseases.
本发明公开了一株具有体外降胆固醇作用的屎肠球菌。本发明所述屎肠球菌WEFA23保藏于中国微生物菌种保藏管理委员会普通微生物中心,保藏地点为武汉市中国典型培养物保藏中心,保藏号为CCTCCM 2015785,保藏日期为2015年12月28日。本发明所述屎肠球菌分离于婴 |
---|